Evidence also showed that the peptide HCBP-1 has exhibited specific binding to lung cancer stem cells, suggesting that this peptide may be used to identify lung cancer stem cells and as a drug carrier to lung cancer stem cells [26]. Here, ACY3 is linked to lung cancer.